Treatment with retifanlimab plus carboplatin-paclitaxel statistically significantly reduced the risk of progression or death by 37% compared with placebo plus carboplatin-paclitaxel.

The average annual national percentage change in mortality from hepatocellular carcinoma from 2005 to 2023 was higher for rural vs urban residents.

The FDA has designated Otulfi (ustekinumab-aauz) as an interchangeable biosimilar to the reference product Stelara ...

Metabolic dysfunction-associated steatotic liver disease in pregnant women is a risk factor for preterm birth.

Novo Nordisk is teaming up with Septerna to develop new pills to treat obesity, type 2 diabetes, and other metabolic diseases.

GLP-1 RAs are associated with a significant decrease in apnea-hypopnea index among patients with moderate to severe OSA and without diabetes.

In patients with Barrett esophagus, EAC significantly increased all-cause mortality, but rates remained elevated after excluding EAC-related deaths.

HealthDay News — Nebraska is the first state to get federal approval to ban the purchase of soda and energy drinks under the Supplemental Nutrition Assistance Program (SNAP), also known as food stamps ...

Most top-selling liver supplements on Amazon lack strong scientific evidence for safety or efficacy, with many relying on limited research.

House Republicans have proposed cuts to Medicaid funding, which could be devastating to America’s rural hospitals.

Sarcopenia in the United States appears to be correlated to gallstone risk, most significantly among women, according to study results published in BMC Gastroenterology.

In adults with nonalcoholic fatty liver disease and obesity, the estimated glucose disposal rate strongly negatively correlated with liver fibrosis severity.